Watson seeks approval of generic version of cancer drug Velcade
December 28, 2012 at 10:46 AM EST
Dec 28 (Reuters) - Watson Pharmaceuticals Inc said on Friday it has applied for U.S. approval to market a generic version of Velcade, a treatment for multiple myeloma made by Takeda Pharmaceutical Co.
